Deletion of SHP-2 in mesenchymal stem cells causes growth retardation, limb and chest deformity, and calvarial defects in mice
SUMMARY In mice, induced global disruption of the Ptpn11 gene, which encodes the SHP-2 tyrosine phosphatase, results in severe skeletal abnormalities. To understand the extent to which skeletal abnormalities can be attributed to perturbation of SHP-2 function in bone-forming osteoblasts and chondroc...
Main Authors: | Philip E. Lapinski, Melissa F. Meyer, Gen-Sheng Feng, Nobuhiro Kamiya, Philip D. King |
---|---|
Format: | Article |
Language: | English |
Published: |
The Company of Biologists
2013-11-01
|
Series: | Disease Models & Mechanisms |
Online Access: | http://dmm.biologists.org/content/6/6/1448 |
Similar Items
-
Development of severe skeletal defects in induced SHP-2-deficient adult mice: a model of skeletal malformation in humans with SHP-2 mutations
by: Timothy J. Bauler, et al.
Published: (2011-03-01) -
Calvary
by: Irina Z. Surat
Published: (2022-09-01) -
Treg-specific deletion of the phosphatase SHP-1 impairs control of inflammation in vivo
by: QinLei Gu, et al.
Published: (2023-03-01) -
Differentiation potential of mesenchymal progenitor cells following transplantation into calvarial defects
by: Lam, Chris X. F., et al.
Published: (2013) -
Microbial products linked to steatohepatitis are reduced by deletion of nuclear hormone receptor SHP in mice
by: Ryan Mifflin, et al.
Published: (2023-12-01)